During the past decade, Saint Vincent Healthcare conducted 103 clinical trials. In the 10-year time frame, 103 clinical trials started and 125 clinical trials were completed, i.e. on average, 121.4% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 65 clinical trials were completed. i.e. 282.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Vincent Healthcare" #1 sponsor was "National Cancer Institute (NCI)" with 128 trials, followed by "SWOG Cancer Research Network" with 49 trials sponsored, "Alliance for Clinical Trials in Oncology" with 40 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored and "GOG Foundation" with 15 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Vincent Healthcare" #1 collaborator was "National Cancer Institute (NCI)" with 127 trials as a collaborator, "NRG Oncology" with 18 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator and "Eastern Cooperative Oncology Group" with 8 trials as a collaborator. Other collaborators include 40 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Saint Vincent Healthcare" are "Breast Cancer" (14 trials), "Recurrent Breast Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Invasive Breast Carcinoma" (7 trials) and "Stage IIIB Breast Cancer AJCC v7" (7 trials). Many other conditions were trialed in "Saint Vincent Healthcare" in a lesser frequency.

Most popular intervention types in "Saint Vincent Healthcare" are "Drug" (217 trials), "Other" (154 trials), "Biological" (108 trials), "Procedure" (53 trials) and "Radiation" (27 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (92 trials), "Quality-of-Life Assessment" (53 trials), "Paclitaxel" (28 trials), "Carboplatin" (26 trials) and "Questionnaire Administration" (26 trials). Other intervention names were less common.

The vast majority of trials in "Saint Vincent Healthcare" are 202 trials for "All" genders, 50 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Vincent Healthcare". undefined are not yet recruiting, 27 are recruiting, 110 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 93 completed trials in Saint Vincent Healthcare, 4 suspended trials, and 22 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Vincent Healthcare, 11 "Phase 1" clinical trials were conducted, 125 "Phase 2" clinical trials and 132 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".

Saint Vincent Healthcare has several departments that took part in Clinical trials: "St. Vincent Healthcare Cancer Care Services" - 329 trials, "Cancer Center of Colorado at Sloan's Lake" - 58 trials, "Eastern Montana Cancer Center" - 21 trials, "St. Vincent's Heart and Vascular Center" - 2 trials